Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("BENSERAZIDE")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 227

  • Page / 10

Export

Selection :

  • and

IMPROVED CONTROL OF BRITTLE PARKINSONISM BY SEPARATE ADMINISTRATION OF LEVODOPA AND BENSERAZIDEMCLELLAN DL; DEAN BC.1982; BR. MED. J.; ISSN 0007-1447; GBR; DA. 1982; VOL. 284; NO 6321; PP. 1001-1002Article

PERFUSIONS DE L-5-HTP, ASSOCIEES A UN INHIBITEUR DE LA DECARBOXYLASE, CHEZ LE LAPIN. DONNEES POLYGRAPHIQUES ET BIOCHIMIQUES.AUBERT C; GEISSBUEHLER F.1975; PSYCHOPHARMACOLOGIA; ALLEM.; DA. 1975; VOL. 45; NO 1; PP. 97-101; ABS. ANGL.; BIBL. 14 REF.Article

ULTRASTRUKTURELLE UNTERSUCHUNGEN AN EINEM EPIPHYSEOLYSEMODELL. ZELLEN UND MATRIX IN DER PROXIMALEN TIBIAEPIPHYSENFUGE DER RATTE NACH BEHANDLUNG MIT DL SERIN (3,4,5, TRIHYDROXYBENZYL)-HYDRAZID = ETUDE ULTRASTRUCTURALE D'UN MODELE ANIMAL D'EPIPHYSOLYSE. CELLULES ET MATRICE DU CARTILAGE DE CONJUGAISON PROXIMAL DU TIBIA DU RAT APRES ADMINISTRATION DE DL SERINE (TRIHYDROXYBENZYL-3,4,5) HYDRAZIDERIEDE UN; VILLIGER W; MIHATSCH M et al.1975; VIRCHOWS ARCH., B; DTSCH.; DA. 1975; VOL. 17; NO 4; PP. 307-318; ABS. ANGL.; BIBL. 1P. 1/2Article

RISULTATI DEL TRATTAMENTO PROLUNGATO DEL MORBO DI PARKINSON CON L'ASSOCIAZIONE L-DOPA+BENSERAZIDE = LES RESULTATS DU TRAITEMENT PROLONGE DE LA MALADIE DE PARKINSON AVEC L'ASSOCIATION L-DOPA+BENSERAZIDECASSACHIA M; BARBA C; RUGGIERI S et al.1974; RIV. NEUROL.; ITAL.; DA. 1974; VOL. 44; NO 5; PP. 303-330; ABS. FR. ANGL. ALLEM.; BIBL. 23REF.Article

Simultaneous determination of levodopa and benserazide by stopped-flow injection analysis and three-way multivariate calibration of kinetic-spectrophotometric dataPISTONESI, Marcelo; CENTURION, Maria E; FERNANDEZ BAND, Beatriz S et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 36, Num 3, pp 541-547, issn 0731-7085, 7 p.Article

Kinetic Characterization of the Oxidation of Carbidopa and Benserazide by Tyrosinase and PeroxidaseMUNOZ-MUNOZ, Joseph Louis; GARCIA-MOLINA, Francis; GARCIA-MOLINA, Mary et al.Bioscience, biotechnology, and biochemistry. 2009, Vol 73, Num 6, pp 1308-1313, issn 0916-8451, 6 p.Article

Difference spectrophotometric assay of 1,2-diphenolic drugs in pharmaceutical formulations. III: The simultaneous assay of levodopa and benserazideDAVIDSON, A. G.Journal of pharmaceutical and biomedical analysis. 1985, Vol 3, Num 3, pp 235-240, issn 0731-7085Article

Dopaminergic drugs improve human visual contrast sensitivityDOMENICI, L; TRIMARCHI, C; PICCOLINO, M et al.Human neurobiology. 1985, Vol 4, Num 3, pp 195-197, issn 0721-9075Article

DIFFERENTIAL EFFECT OF BENSERAZIDE (R04-4602) ON THE CONCENTRATION OF INDOLEAMINES IN RAT PINEAL AND HYPOTHALAMUSARENDT J; HO AK; LAUD C et al.1981; BR. J. PHARMACOL.; ISSN 0007-1188; GBR; DA. 1981; VOL. 72; NO 2; PP. 257-262; BIBL. 26 REF.Article

POSTANOXIC MYOCLONUS. TREATMENT OF A CASE WITH 5-HYDROXYTRYPTOPHANE AND A DECARBOXYLASE INHIBITORBERETTA E; REGLI V; DE CROUSAZ G et al.1981; J. NEUROL.; DEU; DA. 1981; VOL. 225; NO 1; PP. 57-62; ABS. GER; BIBL. 35 REF.Article

CONDUITE PRATIQUE DU TRAITEMENT DE LA MALADIE DE PARKINSON PAR LA LEVODOPA ASSOCIEE A UN INHIBITEUR DE LA DECARBOXYLASE (MODOPAR)SHOTT B; CHAZOT G.1975; J. MED. LYON; FR.; DA. 1975; VOL. 56; NO 1297; PP. 1141-1143Article

EFFET D'UN INHIBITEUR DE LA DECARBOXYLASE SUR LA DOPA PLASMATIQUE ENDOGENE CHEZ L'HOMMEGEISSBUHLER F; CONSTANTINIDIS J; GAILLARD JM et al.1974; BIOMEDICINE; FR.; DA. 1974; VOL. 21; NO 7; PP. 297-298; ABS. ANGL.; BIBL. 10REF.Article

IMPORTANCE OF TRYPTOPHAN PYRROLASE AND AROMATIC AMINO ACID DECARBOXYLASE IN THE CATABOLISM OF TRYPTOPHAN.YOUNG SN; ST ARNAUD MCKENZIE D; SOURKES TL et al.1978; BIOCHEM. PHARMACOL.; G.B.; DA. 1978; VOL. 27; NO 5; PP. 763-767; BIBL. 24 REF.Article

LEVODOPA AND DECARBOXYLASE INHIBITORS: A REVIEW OF THEIR CLINICAL PHARMACOLOGY AND USE IN THE TREATMENT OF PARKINSONISMPINDER RM; BROGDEN RN; SAWYER PR et al.1976; DRUGS; SWITZ.; DA. 1976; VOL. 11; NO 5; PP. 329-377; BIBL. 6 P.Article

RESULTATS APRES TROIS A CINQ ANS DE TRAITEMENT DE 219 SYNDROMES PARKINSONIENS PAR LA L-DOPA ET LES ASSOCIATIONS L-DOPA INHIBITEUR DE LA DECARBOXYLASEBOUDIN G; PEPIN B; GUILLARD A et al.1975; J. MED. MONTPELLIER; FR.; DA. 1975; VOL. 10; NO 2; PP. 72-76Article

A HISTOCHEMICAL STUDY ON THE CENTRAL EFFECT OF MONOAMINE PRECURSORS. = UNE ETUDE HISTOCHIMIQUE SUR L'EFFET CENTRAL DES PRECURSEURS DE LA MONOAMINEKATO N; MURASE Y.1975; FOLIA PSYCHIATR. NEUROL. JAP.; JAP.; DA. 1975; VOL. 29; NO 2; PP. 188-195; BIBL. 12 REF.Article

Determination of binary mixtures of levodopa and benserazide in pharmaceuticals by ratio-spectra derivative spectrophotometryUSLU, Bengi; ÖZKAN, Sibel A.Analytical letters. 2002, Vol 35, Num 2, pp 303-314, issn 0003-2719Article

Etude clinique du Madopar dans la Maladie de ParkinsonSHINTANI, T.Yakuri to chiryo. 1987, Vol 15, Num 1, pp 319-324, issn 0386-3603Article

BENSERAZIDE INDUCES MIGRAINE ATTACKS. IRRELEVANCE OF CONCOMITANT HYPERPROLACTINEMIAPOLLERI A; MURIALDO G; MARTIGNONI E et al.1979; FARMACO, ED. SCI.; ITA; DA. 1979; VOL. 34; NO 5; PP. 465-468; ABS. ITA; BIBL. 10 REF.Article

THE EFFECTS OF AROMATIC AMINO ACID DECARBOXYLASE INHIBITORS ON PLASMA CONCENTRATIONS OF 5-HYDROXYTRYPTOPHAN IN MANMAGNUSSEN I; ENGBAEK F.1978; ACTA PHARMACOL. TOXICOL.; DNK; DA. 1978; VOL. 43; NO 1; PP. 36-42; BIBL. 19 REF.Article

ACTION A LONG TERME DE LA L-DOPA SEULE ET EN ASSOCIATION AVEC LE BENSERAZIDE SUR LES SYNDROMES PARKINSONIENSROUGIER A; ROQUES JC; HENRY P et al.1975; GAZ. MED. FR.; FR.; DA. 1975; VOL. 82; NO 39; PP. 4683-4690 (8P.); BIBL. 20 REF.Article

DEVELOPPEMENT DES ETUDES SUR LE TRAITEMENT DES SYNDROMES PARKINSONIENS PAR LA LEVODOPA. I. EFFETS A COURT ET MOYEN TERMES (DEUX ANS) DE L'ASSOCIATION LEVODOPA-INHIBITEUR DE LA DECARBOXYLASE.RONDOT P; DUMAS JLR; CARDON P et al.1975; THERAPIE; FR.; DA. 1975; VOL. 30; NO 5; PP. 653-666; ABS. ANGL.; BIBL. 1 P. 1/2Article

LA NOSTRA ESPERIENZA NEL TRATTAMENTO DEL MORBO DI PARKINSON CON L'ASSOCIAZIONE L-DOPA + RO 4-4602 = NOTRE EXPERIENCE DU TRAITEMENT DE LA MALADIE DE PARKINSON PAR L'ASSOCIATION L-DOPA+ RO 4-4602CAMPANELLA G; PENNETTA R.1974; ACTA NEUROL.; ITAL.; DA. 1974; VOL. 29; NO 3; PP. 252-263; ABS. ANGL.; BIBL. 6 REF.Article

LACK OF COUNTERACTING EFFECT OF LIPOSOMES ON BENSERAZIDE-INDUCED HYPERPROLACTINEMIAMURIALDO G; MASTURZO P; POLLERI A et al.1979; NEUROPSYCHOBIOLOGY; CHE; DA. 1979; VOL. 5; NO 6; PP. 317-321; BIBL. 11 REF.Article

ESSAI DE POTENTIALISATION DE L'ACTION DE LA L-DOPA SUR LA SECRETION DE L'HORMONE DE CROISSANCE PAR LA BENSERAZIDE, LE DISULFIRAME ET LE PROPRANOLOLROCHICCIOLI P; ENJAUME P; DUTAU G et al.1976; ARCH. FR. PEDIATR.; FR.; DA. 1976; VOL. 33; NO 1; PP. 55-66; ABS. ANGL.; BIBL. 1 P. 1/2Article

  • Page / 10